| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls 1958 Birth Cohort Controls Jones Richard W. 18 McArdle Wendy L. 18 Ring ... Nature 447 (7145), 661-678, 2007 | 9607 | 2007 |
| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus M Petri, AM Orbai, GS Alarcón, C Gordon, JT Merrill, PR Fortin, IN Bruce, ... Arthritis & Rheumatism 64 (8), 2677-2686, 2012 | 6140 | 2012 |
| Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants 1958 Birth Cohort Controls: Jones Richard W 18 McArdle Wendy L 18 Ring Susan ... Nature genetics 39 (11), 1329-1337, 2007 | 1481 | 2007 |
| Trial of anifrolumab in active systemic lupus erythematosus EF Morand, R Furie, Y Tanaka, IN Bruce, AD Askanase, C Richez, ... New England Journal of Medicine 382 (3), 211-221, 2020 | 1196 | 2020 |
| Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls Nature 464 (7289), 713-720, 2010 | 941 | 2010 |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for … GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ... Annals of the rheumatic diseases 69 (12), 2074-2082, 2010 | 933 | 2010 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 882 | 2014 |
| A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci Y Liu, C Helms, W Liao, LC Zaba, S Duan, J Gardner, C Wise, A Miner, ... PLoS genetics 4 (4), e1000041, 2008 | 848 | 2008 |
| BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus … DA Isenberg, A Rahman, E Allen, V Farewell, M Akil, IN Bruce, D D'cruz, ... Rheumatology 44 (7), 902-906, 2005 | 747 | 2005 |
| Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A S Nejentsev, JMM Howson, NM Walker, J Szeszko, SF Field, HE Stevens, ... Nature 450 (7171), 887-892, 2007 | 721 | 2007 |
| The frequency and outcome of lupus nephritis: results from an international inception cohort study JG Hanly, AG O’Keeffe, L Su, MB Urowitz, J Romero-Diaz, C Gordon, ... Rheumatology 55 (2), 252-262, 2016 | 668 | 2016 |
| Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort IN Bruce, AG O'Keeffe, V Farewell, JG Hanly, S Manzi, L Su, DD Gladman, ... Annals of the rheumatic diseases 74 (9), 1706-1713, 2015 | 623 | 2015 |
| Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study IN Bruce, MB Urowitz, DD Gladman, D Ibañez, G Steiner Arthritis & Rheumatism 48 (11), 3159-3167, 2003 | 570 | 2003 |
| Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial DJ Wallace, RA Furie, Y Tanaka, KC Kalunian, M Mosca, MA Petri, ... The Lancet 392 (10143), 222-231, 2018 | 529 | 2018 |
| Essential role for the p110δ phosphoinositide 3-kinase in the allergic response K Ali, A Bilancio, M Thomas, W Pearce, AM Gilfillan, C Tkaczyk, N Kuehn, ... Nature 431 (7011), 1007-1011, 2004 | 510 | 2004 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 463 | 2024 |
| Rheumatoid arthritis association at 6q23 W Thomson, A Barton, X Ke, S Eyre, A Hinks, J Bowes, R Donn, ... Nature genetics 39 (12), 1431-1433, 2007 | 458 | 2007 |
| Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis U Hüffmeier, S Uebe, AB Ekici, J Bowes, E Giardina, E Korendowych, ... Nature genetics 42 (11), 996-999, 2010 | 443 | 2010 |
| Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial RA Furie, EF Morand, IN Bruce, S Manzi, KC Kalunian, EM Vital, TL Ford, ... The Lancet Rheumatology 1 (4), e208-e219, 2019 | 439 | 2019 |
| The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults C Gordon, MB Amissah-Arthur, M Gayed, S Brown, IN Bruce, D D’Cruz, ... Rheumatology 57 (1), e1-e45, 2018 | 435 | 2018 |
